Так видимо, их теперь окончательно запугали, даже говорить правду на конференциях и т.п. видимо нельзя.. Хотя я думала, что уж Ян Геннадьевич-то не поддастся на эти провокации.. видимо в угол совсем загнали..

UC scientists to study generic vs. brand name drugs for transplants

Business Courier by James Ritchie, Staff Reporter
Date: Friday, October 19, 2012, 2:18pm EDT

концентрация- 13,

Цинциннати будет использовать 2,7 млн. долл. США

По рецепту на 0,5 дали Програф, по рецепту на 1 мг-такролисиммус

UC scientists to study generic vs. brand name drugs for transplants

Business Courier by James Ritchie, Staff Reporter
Date: Friday, October 19, 2012, 2:18pm EDT

University of Cincinnati researchers will use a $2.7 million grant to study whether there’s a difference between generic versus brand drugs for transplant patients.
The funding from the U.S. Food and Drug Administration will support a clinical trial examining the immunosuppressant tacrolimus (Prograf) against two other generic manufacturers in liver and kidney transplant patients.

Tacrolimus is a “critical dose drug,” meaning the amount has to be just right or the patient risks side effects. It is used after transplant to reduce the activity of the patient’s immune system and lower the risk of rejection.
Because of the dose sensitivity – too much can be toxic, too little can lead to rejection of the organ – physicians have been concerned about whether the branded and generic products are equal.

“Currently more than 50 percent of transplant patients are dispensed generic tacrolimus,” said Rita Alloway, UC research professor of medicine and director of transplant clinical research. “The largest concern for clinicians is the switchability between various generics. When patients receive their prescription, they could be getting medication from different manufacturers each month.”

The trial will enroll 72 transplant patients of UC Health University Hospital and Christ Hospital transplant programs starting early 2013.

Xenia, спасибо!